U.S., April 5 -- ClinicalTrials.gov registry received information related to the study (NCT03099421) titled 'Prostatic Artery Embolization for Benign Prostatic Obstruction' on March 28.
Brief Summary: The aim of this study is to investigate the safety and efficacy of prostatic artery embolization (PAE) for patients who refuse or are not eligible for surgery with moderate-severe lower urinary tract symptoms or indwelling catheter secondary to benign prostate obstruction due to benign prostatic hyperplasia.
Study Start Date:
Study Type: Interventional
Condition: Hyperplasia Prostatic
Lower Urinary Tract Symptoms
Prostatic Diseases
Urological Manifestations
Intervention: Procedure: Prostatic Artery Embolization
The procedure is performed with the patient under local anaesthetic and if necessary sedation. We will be using a percutaneous transfemoral approach, super-selective catheterisation of small prostatic arteries is carried out using microcatheters. Embolisation will be done using microspherical embolic material.
Recruitment Status: Recruiting
Sponsor: Rigshospitalet, Denmark
Information provided by (Responsible Party): Brian Malling, Rigshospitalet, Denmark
Published by HT Digital Content Services with permission from Health Daily Digest.